BioArctic AB is a Sweden‑based biopharmaceutical company specializing in the discovery and development of disease‑modifying treatments for neurodegenerative disorders. The Company’s primary focus is on conditions that affect the central nervous system (CNS), including Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis (ALS), areas characterized by high unmet medical need and limited effective therapies. BioArctic AB conducts advanced research and development of innovative biological drugs, with a particular emphasis on monoclonal antibodies designed to target the underlying disease mechanisms rather than only alleviating symptoms. The Company combines in‑house scientific expertise with strategic collaborations with global pharmaceutical partners to advance and commercialize its therapeutic candidates worldwide.
Back to dashboard
Company Information
About this company
Key people
Eugen Steiner
Independent Chairman of the Board
Anna-Kaija Groenblad
Chief Commercial Officer
Gabrielle Ahlberg Hillert Hillert
Chief Medical Officer, Head of Clinical & Regulatory Affairs
Lars Lannfelt
Founder, Director, Senior Vice President University Collaborations
Cecilia Edstroem
Independent Director
Anna-Lena Engwall
Independent Director
Charlotta Ljungqvist
Independent Director
Gunilla Osswald
President, Chief Executive Officer
Anders Martin-Loef
Chief Financial Officer, Company Secretary
Oskar Bosson
Vice President, Head of Investor Relations and Communications
Rebecca Kastell
Vice President, Head of Human Resource
Mikael Moge
Vice President - Chemistry, Manufacturing and Control
Biljana Rizoska
Vice President, Head of Research
Emilie Ankarcrona Smith
General Counsel, Head of Legal & IP
Johanna Falting
Chief R&D Officer, Head of Research & Development
Click to see more
Key facts
- Shares in issue74.32m
- EPICBIOA B
- ISINSE0010323311
- LocationSweden
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market capSEK 21.49bn
- Employees150
- ExchangeStockholm Stock Exchange
- IndexSX All Share PI Market Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.